| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Asset impairment | NaN | NaN | 138,483 | 0 |
| Loss (gain) on foreign exchange | NaN | NaN | 0 | 0 |
| Net loss | -42,317 | -39,941 | -222,187 | -134,954 |
| Depreciation and amortization expense | 8,081 | 8,265 | 19,234 | 37,308 |
| Amortization of operating lease right-of-use assets | 1,010 | 833 | 903 | 1,296 |
| Non-cash interest expense | 1,340 | 2,045 | 1,010 | 1,815 |
| Loss on digital assets, net | -1,946 | -3,734 | -383 | NaN |
| Loss on disposal of property and equipment, net | -328 | -744 | -1,395 | -320 |
| Asset impairment | NaN | 137,435 | NaN | NaN |
| Goodwill impairment | NaN | 4,450 | NaN | NaN |
| Impairment of intangible assets, including goodwill | 2,255 | NaN | NaN | NaN |
| Stock-based compensation | -802 | 658 | 1,294 | 1,198 |
| Reserve on inventory | NaN | 3,444 | 10,632 | 3,753 |
| Credit loss expense | 143 | 4,294 | NaN | NaN |
| Accrued interest on short-term note receivable | 185 | 189 | NaN | NaN |
| Payments for operating expenses made with digital assets | 338 | NaN | NaN | NaN |
| Loss on settlement of notes payable-Nonrelated Party | -8,431 | -15,629 | -46,517 | -38,378 |
| Loss on settlement of notes payable-Related Party | 0 | -2,088 | 0 | -3,040 |
| H.s.l. srl. settlement adjustment | 0 | 0 | 0 | 295 |
| Financial obligations on lease back transaction | NaN | NaN | NaN | 0 |
| Settlement on accrued research and development expenses | NaN | 0 | 0 | NaN |
| Gain from forgiveness of accounts payable and deposits, net | NaN | NaN | NaN | 0 |
| Change in fair value of notes payable, warrant liabilities, and derivative liabilities | 2,771 | 12,372 | 31,341 | 5,380 |
| Change in fair value of related party notes payable, warrant liabilities, and derivative liabilities | 1,439 | 1,656 | 2,144 | -5,427 |
| Other | 267 | 195 | -82 | -168 |
| Accounts receivables | 16 | -332 | -56 | 645 |
| Accrued expenses and other current liabilities-Nonrelated Party | NaN | -13,575 | 6,403 | 11,241 |
| Inventory | -2,029 | 762 | -838 | -630 |
| Accrued expenses and other current liabilities-Related Party | NaN | 364 | 1,314 | -11 |
| Related party accrued interest expense-Related Party | NaN | 0 | 96 | -96 |
| Deposits | 2,678 | 2,958 | -4,913 | 2,331 |
| Accounts payable | -3,761 | -5,005 | -6,779 | -4,059 |
| Accrued expenses and other current and non-current liabilities-Nonrelated Party | -1,644 | NaN | NaN | NaN |
| Other current and non-current assets | NaN | NaN | NaN | -1,566 |
| Accrued expenses and other current and non-current liabilities-Related Party | -349 | NaN | NaN | NaN |
| Operating lease liabilities | -2,521 | -888 | -707 | -1,977 |
| Financing lease liabilities | NaN | 0 | 0 | NaN |
| Other current and non-current assets | -1,377 | -3,304 | 4,392 | NaN |
| Net cash used in operating activities | -31,472 | -28,405 | -35,563 | -43,608 |
| Investment in qualigen therapeutics, inc., net of cash acquired | NaN | NaN | -8,777 | NaN |
| Acquisition of aixc, net of cash acquired | NaN | 1,121 | NaN | NaN |
| Proceeds from sale of equipment | NaN | 32 | 0 | 0 |
| Purchase of digital assets | 338 | 16,500 | 10,500 | NaN |
| Sale of digital assets | 2,107 | 4,107 | 8,525 | NaN |
| Payments for property and equipment | 221 | 1,119 | 1,518 | 5,007 |
| Purchase of short-term note receivable | NaN | 100 | NaN | NaN |
| Payments for intangible assets | 274 | 256 | NaN | NaN |
| Net cash provided (used in) investing activities | 1,274 | -23,734 | 5,284 | -5,007 |
| Proceeds from aixc follow-on capital contribution, net of issuance costs | NaN | 9,899 | NaN | NaN |
| Payments of notes payable issuance costs-Nonrelated Party | NaN | 0 | -51,110 | 48,570 |
| Payments of notes payable issuance costs-Related Party | NaN | -3,457 | -5,161 | 4,601 |
| Payments of notes payable and other financing obligations | NaN | 450 | 4,482 | NaN |
| Capital contributions | NaN | 0 | NaN | NaN |
| Proceeds from notes payable, net of original issuance discount-Nonrelated Party | 8,820 | 19,348 | 132,391 | NaN |
| Proceeds from notes payable, net of original issuance discount-Related Party | 0 | 0 | 4,731 | NaN |
| Proceeds from other financial obligations | 0 | 279 | 418 | 4,384 |
| Payments of notes payable issuance costs | -1,034 | NaN | NaN | 1,521 |
| Payments of notes payable and other financing obligations-Nonrelated Party | -14 | NaN | NaN | 367 |
| Proceeds from exercise of warrants | NaN | 0 | -1,441 | NaN |
| Payments of notes payable and other financing obligations-Related Party | -470 | NaN | NaN | 615 |
| Net cash provided by financing activities | 7,835 | 25,619 | 80,731 | 55,052 |
| Effect of exchange rate changes on cash and restricted cash | -331 | -1,463 | -776 | -350 |
| Net increase in cash and restricted cash | -22,694 | -27,983 | 49,676 | 6,087 |
| Cash and restricted cash, beginning of period | 34,954 | 62,937 | 7,174 | NaN |
| Cash and restricted cash, end of period | 12,260 | 34,954 | 62,937 | NaN |
FARADAY FUTURE INTELLIGENT ELECTRIC INC. (FFAI)
FARADAY FUTURE INTELLIGENT ELECTRIC INC. (FFAI)